Scopolamine Transdermal System 1 mg/1
scopolamine transdermal system · PATCH, EXTENDED RELEASE · Padagis Israel Pharmaceuticals Ltd
Scopolamine Transdermal System is a patch, extended release containing scopolamine transdermal system at 1 mg/1, taken transdermal. Manufactured by Padagis Israel Pharmaceuticals Ltd.
Key Facts
- Brand Name
- Scopolamine Transdermal System
- Generic Name
- scopolamine transdermal system
- NDC Code (Product)
45802-580- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Strength
- 1 mg/1
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- Application #
- ANDA078830
- Drug Class
- Anticholinergic [EPC]
- Marketing Start
- 06/13/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Scopolamine Transdermal System used for?
Scopolamine Transdermal System contains scopolamine transdermal system. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.
Is Scopolamine Transdermal System a controlled substance?
Scopolamine Transdermal System is not classified as a controlled substance by the DEA.
What is the generic name for Scopolamine Transdermal System?
The generic name for Scopolamine Transdermal System is scopolamine transdermal system. There are no other listed brand versions of scopolamine transdermal system.
What is the NDC code for Scopolamine Transdermal System 1 mg/1?
The NDC (National Drug Code) for Scopolamine Transdermal System 1 mg/1 is 45802-580, listed by Padagis Israel Pharmaceuticals Ltd.
Other Scopolamine Transdermal System Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)